ArticleCardiovascular diabetology2014

The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients.

Nicol Poncina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.